Gilead Sciences (GILD) Enterprise Value (2009 - 2026)
Gilead Sciences (GILD) recorded Enterprise Value of $184.97 billion in Q3 2026, up 41.8% from $130.43 billion a year earlier and up 20.5% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Enterprise Value (2009 - 2026) Analysis & Trends
For FY2025, Gilead Sciences reported Enterprise Value of $144.6 billion, up 37.7% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of 17.1% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $105.02 billion in FY2024 (+12.2%), $93.59 billion in FY2023 (-7.0%), $100.64 billion in FY2022 (+19.1%) and $84.53 billion in FY2021 (+28.7%).
- The Q3 2026 figure is the highest quarterly Enterprise Value in data going back to Q1 2009.
- On a year-over-year basis, Enterprise Value has increased for nine consecutive quarters, with growth averaging 34.6% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 60.2% in Q2 2025, against a decline of 12.5% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $153.52 billion (Q2 2026), $165.37 billion (Q1 2026) and $144.6 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 178.45 Bn |
| Jun 30, 2026 | 153.52 Bn |
| Mar 31, 2026 | 165.37 Bn |
| Dec 31, 2025 | 144.60 Bn |
| Sep 30, 2025 | 130.43 Bn |
| Jun 30, 2025 | 132.40 Bn |
| Mar 31, 2025 | 131.49 Bn |
| Dec 31, 2024 | 105.02 Bn |
| Sep 30, 2024 | 99.34 Bn |
| Jun 30, 2024 | 82.63 Bn |
| Mar 31, 2024 | 86.47 Bn |
| Dec 31, 2023 | 93.59 Bn |
| Sep 30, 2023 | 86.51 Bn |
| Jun 30, 2023 | 89.38 Bn |
| Mar 31, 2023 | 97.62 Bn |
| Dec 31, 2022 | 100.64 Bn |
| Sep 30, 2022 | 71.68 Bn |
| Jun 30, 2022 | 71.83 Bn |
| Mar 31, 2022 | 69.27 Bn |
| Dec 31, 2021 | 84.53 Bn |
API Access
Gilead Sciences Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();